Preclinical Evaluation of the Thrombogenicity and Endothelialization of Bare Metal and Surface-Coated Neurovascular Stents

References

1. 1.↵
   2. Higashida RT,
   3. Smith W,
   4. Gress D, et al

   . Intravascular stent and endovascular coil placement for a ruptured fusiform aneurysm of the basilar artery: case report and review of the literature. J Neurosurg 1997;87:944–49

   CrossRefPubMedWeb of Science
2. 2.↵
   2. McLaughlin N,
   3. McArthur DL,
   4. Martin NA

   . Use of stent-assisted coil embolization for the treatment of wide-necked aneurysms: a systematic review. Surg Neurol Int 2013;4:43

   CrossRefPubMed
3. 3.↵
   2. O'Kelly CJ

   . Should stents be used in the treatment of ruptured intracranial aneurysms? J Neurosurg Sci 2011;55:27–33

   PubMed
4. 4.↵
   2. Wanke I,
   3. Forsting M

   . Stents for intracranial wide-necked aneurysms: more than mechanical protection. Neuroradiology 2008;50:991–98

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Mocco J,
   3. Fargen KM,
   4. Albuquerque FC, et al

   . Delayed thrombosis or stenosis following Enterprise-assisted stent-coiling: is it safe? Midterm results of the interstate collaboration of Enterprise stent coiling. Neurosurgery 2011;69:908–13, discussion 913–14

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Ries T,
   3. Buhk JH,
   4. Kucinski T, et al

   . Intravenous administration of acetylsalicylic acid during endovascular treatment of cerebral aneurysms reduces the rate of thromboembolic events. Stroke 2006;37:1816–21

   Abstract/FREE Full Text
7. 7.↵
   2. Golshani K,
   3. Ferrel A,
   4. Lessne M, et al

   . Stent-assisted coil embolization of ruptured intracranial aneurysms: a retrospective multicenter review. Surg Neurol Int 2012;3:84

   CrossRefPubMed
8. 8.↵
   2. Marois Y,
   3. Chakfe N,
   4. Guidoin R, et al

   . An albumin-coated polyester arterial graft: in vivo assessment of biocompatibility and healing characteristics. Biomaterials 1996;17:3–14

   CrossRefPubMed
9. 9.↵
   2. Mulvihill JN,
   3. Faradji A,
   4. Oberling F, et al

   . Surface passivation by human albumin of plasmapheresis circuits reduces platelet accumulation and thrombus formation: experimental and clinical studies. J Biomed Mater Res 1990;24:155–63

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Chen J,
    3. Chen C,
    4. Chen Z, et al

    . Collagen/heparin coating on titanium surface improves the biocompatibility of titanium applied as a blood-contacting biomaterial. J Biomed Mater Res A 2010;95:341–49

    PubMed
11. 11.↵
    2. Johnson I,
    3. Perchy D,
    4. Liu H

    . In vitro evaluation of the surface effects on magnesium-yttrium alloy degradation and mesenchymal stem cell adhesion. J Biomed Mater Res A 2012;100:477–85

    PubMed
12. 12.↵
    2. Avci-Adali M,
    3. Kobba J,
    4. Neumann B, et al

    . Application of a rotating bioreactor consisting of low-cost and ready-to-use medical disposables for in vitro evaluation of the endothelialization efficiency of small-caliber vascular prostheses. J Biomed Mater Res B Appl Biomater 2013;101:1061–68

    PubMed
13. 13.↵
    2. Zhao M,
    3. Amin-Hanjani S,
    4. Ruland S, et al

    . Regional cerebral blood flow using quantitative MR angiography. AJNR Am J Neuroradiol 2007;28:1470–73

    Abstract/FREE Full Text
14. 14.↵
    2. Hirsh J,
    3. Siragusa S,
    4. Cosmi B, et al

    . Low-molecular-weight heparins (LMWH) in the treatment of patients with acute venous thromboembolism. Thromb Haemost 1995;74:360–63

    PubMedWeb of Science
15. 15.↵
    2. Blezer R,
    3. Fouache B,
    4. Willems GM, et al

    . Activation of blood coagulation at heparin-coated surfaces. J Biomed Mater Res 1997;37:108–13

    CrossRefPubMed
16. 16.↵
    2. Klement P,
    3. Du YJ,
    4. Berry L, et al

    . Blood-compatible biomaterials by surface coating with a novel antithrombin-heparin covalent complex. Biomaterials 2002;23:527–35

    CrossRefPubMed
17. 17.↵
    2. Kottke-Marchant K,
    3. Anderson JM,
    4. Umemura Y, et al

    . Effect of albumin coating on the in vitro blood compatibility of Dacron arterial prostheses. Biomaterials 1989;10:147–55

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Bae IH,
    3. Park IK,
    4. Park DS, et al

    . Thromboresistant and endothelialization effects of dopamine-mediated heparin coating on a stent material surface. J Mater Sci Mater Med 2012;23:1259–69

    CrossRefPubMed
19. 19.↵
    2. Moer R,
    3. Myreng Y,
    4. Mølstad P, et al

    . Stenting in small coronary arteries (SISCA) trial: a randomized comparison between balloon angioplasty and the heparin-coated beStent. J Am Coll Cardiol 2001;38:1598–603

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Serruys PW,
    3. Emanuelsson H,
    4. van der Giessen W, et al

    . Heparin-coated Palmaz-Schatz stents in human coronary arteries: early outcome of the Benestent-II Pilot Study. Circulation 1996;93:412–22

    Abstract/FREE Full Text
21. 21.↵
    2. Blindt R,
    3. Vogt F,
    4. Astafieva I, et al

    . A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. J Am Coll Cardiol 2006;47:1786–95

    CrossRefPubMedWeb of Science